Harvard Business School and Harvard Medical School’s collaboration forum on health care innovation, announced the finalists in its Health Acceleration Challenge. The challenge focuses on taking compelling, already-implemented health care solutions and helping them to grow and increase their impact through powerful networking and funding opportunities.
The HBS-HMS Forum on Health Care Innovation is led by a steering committee composed of Cara Sterling, Director of the HBS Health Care Initiative, HBS and HMS professors and health care professionals.
Applicants were given five guiding directives: improve quality of care, lower care delivery costs, and expand access to care, while demonstrating real value and the ability to scale to create broader impact. Chosen applications represented 25 different health care categories.
Bloodbuy, I-PASS, Medalogix and Twine Health were announced as finalists from a group of nearly 500 applicants from 29 countries and 43 states. The teams will share $150,000 in prize money, with an additional $50,000 going to the eventual winner. The winner will be named next year, after the four finalists have pursued their dissemination plans.
All of the winners will give presentations at an invitation-only conference of senior industry leaders and experts to be held in April on the Harvard Business School campus. The teams will also become the subject of a Harvard Business School case study.
The funding for the Health Acceleration Challenge was provided by a generous gift from Howard E. Cox, Jr. (MBA 1969), a former general partner and now advisory partner in one of the country’s first and most successful venture capital firms, Greylock Partners, and a member of both the HBS Healthcare Initiative Advisory Board and the HMS Board of Fellows.